Brief: Viking Therapeutics Highlights Clinical Data From VK2735 Obesity Program In Presentation At ObesityWeek 2025
06/11/2025 12:37
Nov 6 (Reuters) - Viking Therapeutics Inc VKTX.O: VIKING THERAPEUTICS HIGHLIGHTS CLINICAL DATA FROM VK2735 OBESITY PROGRAM IN PRESENTATION AT OBESITYWEEK® 2025 Source text: ID:nPn6RHRxKa Further company coverage: VKTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viking Therapeutics
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry